RecruitingNCT02431845
Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of OCD
Official study title
In SeoulPharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive
OCDMedication studyAges 19–70
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
RecruitingNCT06853587
Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents With Anxiety and Depression
In CalgaryDepression, AnxietyInterventional studyAges 12–17
RecruitingNCT03953014
Pharmacogenetics of Antidepressant-Induced Disinhibition
Official study title
In CalgaryPharmacogenetics of Antidepressant-Induced Disinhibition in Children Study
Depression, OCD, ...Observational studyAges 6–17
RecruitingNCT06763081
Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation
Official study title
In WinnipegPharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation in Children and Youth (PGx-SImBA)
Depression, OCD, ...Observational studyAges 6–24
RecruitingNCT06221358
Pharmacogenomics of Stimulant Treatment Response
Official study title
In CalgaryPharmacogenomics of Stimulant Treatment Response in Children and Adolescents With Attention-Deficit/ Hyperactivity Disorder
ADHDObservational studyAges 6–24
RecruitingNCT06929533
Pharmacogenomics-Supported Psychotropic Prescribing study
Official study title
In WinnipegPharmacogenomics-Supported Psychotropic Prescribing Trial (PGx-SUPPORT): A Pilot Implementation Study in Manitoba
OCDStudy assessmentsAges 18+
RecruitingNCT05490732
Pharmacokinetic Modeling of Methadone
Official study title
In MontpellierPharmacokinetic Population Modeling of Methadone in Patients Managed for Opioid Opioid Addiction
AddictionInterventional studyAges 18–99
RecruitingNCT04278404
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Official study title
Multiple locations, including Palo AltoPharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs
ADHDObservational studyAges 0–20
RecruitingNCT07185815
Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
Official study title
Multiple locations, including AhmedabadA Prospective, Dose Escalating, Open Label, Multi-center, Phase I/IIa Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine.
Depression, Schizophrenia, ...Medication studyAges 18–64
RecruitingNCT06876129
Pharmacologic Augmentation of TMS for Depression With D-serine
In BelmontDepressionMedication studyAges 18–80
RecruitingNCT06410599
Pharmacologic Treatment Augmentation in Chronic Depression
Official study title
Multiple locations, including TübingenPharmacologic Treatment Augmentation in Chronic Depression "Randomized, Controlled, Double Blinded, Phase II Study"
DepressionMedication studyAges 18–64
RecruitingEUCTR 2019-001692-37
Pharmacologic treatment augmentation in chronic depression randomized, controlled, double blinded, phase II study
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including BerlinDepressionHistorical research record
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.